Regeneus Ltd (ASX:RGS) To present at FNN Virtual Investor Event

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today announced that its CEO Leo Lee, will present at the Finance News Network (FNN) CEO Showcase virtual event on Tuesday 25 August 2020 at 12:55pm (AEST). The event is primarily attended by Australian-based retail investors and advisors.

Details of the virtual event can be found here. The presentation will feature an overview of Regeneus' business for new investors, including the Company's platform technologies and recent highlights, including the Kyocera collaboration and licensing agreement for Progenza OA for Japan.

To view the presentation, please visit:
https://abnnewswire.net/lnk/K6Q05JLY


About Regeneus Ltd

Regeneus Ltd (ASX:RGS) is a Sydney-based clinical-stage regenerative medicine company using stem cell technologies to develop a portfolio of novel cell-based therapies. The regenerative therapies seek to address unmet medical needs in human health markets, focusing on neuropathic pain, including osteoarthritis and various skin conditions, with its platform technologies Progenza(TM) and Sygenus. Visit www.regeneus.com.au for more information.

      

Related Companies

Regeneus Ltd